Trials / Completed
CompletedNCT04435223
Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 62 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
SARS-COV 2 infection might be responsible for sever pneumonia. Obesity seems to be a risk factor for severe SARS-COV 2 pneumonia. Lipid metabolism alteration are described with both obesity and sepsis. The aim of the present study was to describe association between lipid metabolism, obesity, sepsis inflammation and clinical outcome in COVID-19 patient with severe pneumonia compared with severe pneumonia caused by other pathogenes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | biological assays in particular on the lipid metabolism | bioassays carried out on samples already collected and conserved |
Timeline
- Start date
- 2020-04-07
- Primary completion
- 2020-05-07
- Completion
- 2020-05-07
- First posted
- 2020-06-17
- Last updated
- 2026-02-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04435223. Inclusion in this directory is not an endorsement.